Literature DB >> 3551136

Sensitivity and specificity of a latex agglutination test for detection of cryptococcal antigen in meningitis.

Y M Coovadia, Z Solwa.   

Abstract

A cryptococcal latex agglutination test (Crypto-La; International Biological Laboratories, Canbury, New Jersey, USA) was evaluated for its ability to detect cryptococcal antigen in cerebrospinal fluid (CSF) specimens obtained from black patients with a clinical diagnosis of meningitis. Of the 445 Gram-stained and bacterial culture-negative CSF specimens routinely tested for cryptococcal antigen, 34 (7,6%) were positive. With the exception of 1 false-positive result, the remaining 33 specimens were obtained from 12 patients in whom the diagnosis of cryptococcal meningitis was confirmed by the isolation of Cryptococcus neoformans. The Crypto-La test gave false-positive results on 1% (4/384) of control CSF specimens tested. Nonspecific agglutination reactions were observed with 1,6% (13/829) of all CSF specimens and 22% (10) of sera tested. The ethylenediaminetetra-acetic heat-extraction method proved reliable in eliminating false-positives and nonspecific agglutination reactions in CSF and serum specimens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3551136

Source DB:  PubMed          Journal:  S Afr Med J


  3 in total

1.  Evaluation of Gen-Probe's Histoplasma capsulatum and Cryptococcus neoformans AccuProbes.

Authors:  K E Huffnagle; R M Gander
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

2.  Elimination of false-positive serum reactivity in latex agglutination test for cryptococcal antigen in human immunodeficiency virus-infected population.

Authors:  S Whittier; R L Hopfer; P Gilligan
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

3.  A comparative evaluation of three methods for the rapid diagnosis of cryptococcal meningitis (CM) among HIV-infected patients in Northern Malawi.

Authors:  Master Ro Chisale; Dikani Salema; Frank Sinyiza; Judith Mkwaila; Pocha Kamudumuli; Hsin-Yi Lee
Journal:  Malawi Med J       Date:  2020-03       Impact factor: 0.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.